REFERENCES
1. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516-37.
2. Griffin C, Agbim U, Ramani A, Shankar N, Kanwal F, Asrani SK. Underestimation of cirrhosis-related mortality in the medicare eligible population, 1999-2018. Clin Gastroenterol Hepatol. 2023;21:223-225.e3.
3. Li Q, Kou Y, Zhang M, et al. Sex-specific and socioeconomic disparities in the global burden of inflammatory bowel disease in 204 countries, 1990-2021: projections to 2050. Front. Immunol. 2026;16:1673212.
4. Ali B, Samuel R, Kramer JR, et al. Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare system. Hepatol Commun. 2026;10.
5. Gu Y, Wu C. The gut-liver axis modulates intestinal immune homeostasis. Mucosal Immunol. 2026;19:1470-80.
6. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012;487:104-8.
7. Yan J, Zeng Y, Guan Z, et al. Inherent preference for polyunsaturated fatty acids instigates ferroptosis of Treg cells that aggravates high-fat-diet-related colitis. Cell Reports. 2024;43:114636.
8. Rodriguez-duque JC, Calleja JL, Iruzubieta P, et al. Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors. Clin Gastroenterol Hepatol. 2023;21:406-414.e7.
9. Sourianarayanane A, Garg G, Smith TH, Butt MI, Mccullough AJ, Shen B. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. J Crohns Colitis. 2013;7:e279-85.
10. Wu S, Liu J, Huang S, Guo Y, Bi Y. Chronic stress induces hepatic steatosis via brain-hepatic sympathetic axis mediated catecholamine resistance. Int. J. Biol. Sci. 2026;22:1407-24.
12. Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol. 2007;74:224-42.
13. Wang T, Tufenkjian A, Ajijola OA, Oka Y. Molecular and functional diversity of the autonomic nervous system. Nat Rev Neurosci. 2025;26:607-22.
14. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2025;54:1481-91.
15. Luo Q, Liu P, Dong Y, Qin T. The role of the hepatic autonomic nervous system. Clin Mol Hepatol. 2023;29:1052-5.
16. Albillos A, De Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72:558-77.
17. Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology. Psychoneuroendocrinology. 2012;37:1369-78.
18. Sgambato D, Miranda A, Ranaldo R, Federico A, Romano M. The role of stress in inflammatory bowel diseases. Curr Pharm Des. 2017;23.
19. Zhai S, Zhu Y, Wang X, et al. Development of a predictive model for radiation pneumonitis based on plasma exosomal miR-200b-5p. Front. Oncol. 2025;15:1516348.
20. Basics of autonomic nervous system function. Clinical Neurophysiology: basis and technical aspects. Elsevier; 2019. pp. 407-18.
22. Sanders KM, Mutafova-Yambolieva VN. Neurotransmitters responsible for purinergic motor neurotransmission and regulation of GI motility. Auton Neurosci. 2021;234:102829.
24. Janig W, Mclachlan EM. Organization of lumbar spinal outflow to distal colon and pelvic organs. Physiol Rev. 1987;67:1332-404.
25. Simmons M. The complexity and diversity of synaptic transmission in the prevertebral sympathetic ganglia. Prog Neurobiol. 1985;24:43-93.
26. Altschuler SM, Escardo J, Lynn RB, Miselis RR. The central organization of the vagus nerve innervating the colon of the rat. Gastroenterology. 1993;104:502-9.
27. De Groat WC, Nadelhaft I, Milne RJ, Booth AM, Morgan C, Thor K. Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst. 1981;3:135-60.
28. Vizzard MA, Brisson M, De Groat WC. Transneuronal labeling of neurons in the adult rat central nervous system following inoculation of pseudorabies virus into the colon. Cell Tissue Res. 2000;299:9-26.
29. Shields RW. Functional anatomy of the autonomic nervous system. J Clin Neurophysiol. 1993;10:2-13.
30. Zhu YF, Wang X, Lowie B, et al. Enteric sensory neurons communicate with interstitial cells of Cajal to affect pacemaker activity in the small intestine. Pflugers Arch - Eur J Physiol. 2013;466:1467-75.
31. Ellis M, Chambers JD, Gwynne RM, Bornstein JC. Serotonin and cholecystokinin mediate nutrient-induced segmentation in guinea pig small intestine. Am J Physiol Gastrointest Liver Physiol. 2013;304:G749-61.
32. Travagli RA, Hermann GE, Browning KN, Rogers RC. Brainstem circuits regulating gastric function. Annu Rev Physiol. 2006;68:279-305.
33. Spencer NJ, Dinning PG, Brookes SJ, Costa M. Insights into the mechanisms underlying colonic motor patterns. J Physiol. 2016;594:4099-116.
34. Furness JB, Callaghan BP, Rivera LR, Cho H. the enteric nervous system and gastrointestinal innervation: integrated local and central control. In: Lyte M, Cryan JF, Editors. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. New York, NY: Springer New York; 2014. pp. 39-71.
35. Parker DR, Wiklendt L, Humenick A, et al. Sympathetic pathways target cholinergic neurons in the human colonic myenteric plexus. Front Neurosci. 2022;16:863662.
37. Horiuchi J, Mcdowall L, Dampney R. Differential control of cardiac and sympathetic vasomotor activity from the dorsomedial hypothalamus. Clin Exp Pharmacol Physiol. 2006;33:1265-8.
38. Hao S, Dulake M, Espero E, Sternini C, Raybould HE, Rinaman L. Central Fos expression and conditioned flavor avoidance in rats following intragastric administration of bitter taste receptor ligands. Am J Physiol Regul Integr Comp Physiol. 2009;296:R528-36.
39. Sartor DM, Verberne AJM. Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow. Am J Physiol Regul Integr Comp Physiol. 2002;282:R1174-84.
40. Holmes GM, Tong M, Travagli RA. Effects of brain stem cholecystokinin-8s on gastric tone and esophageal-gastric reflex. Am J Physiol Gastrointest Liver Physiol. 2009;296:G621-31.
41. Effects of gut bacteria and their metabolites on gut health of animals. Elsevier; 2024. pp. 223-52.
42. Agibalova T, Hempel A, Maurer HC, et al. Vasoactive intestinal peptide promotes secretory differentiation and mitigates radiation-induced intestinal injury. Stem Cell Res Ther. 2024;15:348.
43. Sun M, Wan Y, Shi M, Meng Z, Zeng W. Neural innervation in adipose tissue, gut, pancreas, and liver. Life Metabolism. 2023;2:load022.
44. Miller BM, Oderberg IM, Goessling W. Hepatic nervous system in development, regeneration, and disease. Hepatology. 2021;74:3513-22.
45. Zou J, Li J, Wang X, Tang D, Chen R. Neuroimmune modulation in liver pathophysiology. J Neuroinflammation. 2024;21:188.
46. Luo Q, Liu P, Dong Y, Qin T. The role of the hepatic autonomic nervous system. Clin Mol Hepatol. 2023;29:1052-5.
48. Carty JRE, Devarakonda K, O’connor RM, et al. Amygdala-liver signalling orchestrates glycaemic responses to stress. Nature. 2025;646:697-706.
49. Shimazu T. Innervation of the liver and glucoregulation: Roles of the hypothalamus and autonomic nerves. Nutrition. 1996;12:65-6.
50. Abot A, Lucas A, Bautzova T, et al. Galanin enhances systemic glucose metabolism through enteric Nitric Oxide Synthase-expressed neurons. Mol Metab. 2018;10:100-8.
51. Mundinger TO, Taborsky GJ. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY. Am J Physiol-Endoc M. 2000;278:E390-7.
52. Ren W, Hua M, Cao F, Zeng W. The Sympathetic-immune milieu in metabolic health and diseases: insights from pancreas, liver, intestine, and adipose tissues. Adv Sci. 2023;11:2306128.
53. Liu J, Bisschop PH, Eggels L, et al. Intrahypothalamic Estradiol regulates glucose metabolism via the sympathetic nervous system in female rats. Diabetes. 2013;62:435-43.
54. Liu L, Huang Z, Zhang J, et al. Hypothalamus-sympathetic-liver axis mediates the early phase of stress-induced hyperglycemia in the male mice. Nat Commun. 2024;15:8632.
55. Latour MG, Lautt W. The hepatic vagus nerve in the control of insulin sensitivity in the rat. Auton Neurosci. 2002;95:125-30.
56. Xue C, Aspelund G, Sritharan KC, Wang JP, Slezak LA, Andersen DK. Isolated hepatic cholinergic denervation impairs glucose and glycogen metabolism. J Surg Res. 2000;90:19-25.
57. Lee KC, Miller RE. The hepatic vagus nerve and the neural regulation of insulin secretion*. Endocrinology. 1985;117:307-14.
58. Moore MC, Coate KC, Winnick JJ, An Z, Cherrington AD. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr. 2012;3:286-94.
59. Perseghin G, Regalia E, Battezzati A, et al. Regulation of glucose homeostasis in humans with denervated livers. J Clin Investig. 1997;100:931-41.
60. Mahley RW, Innerarity TL, Rall SC, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25:1277-94.
61. Hurr C, Simonyan H, Morgan DA, Rahmouni K, Young CN. Liver sympathetic denervation reverses obesity‐induced hepatic steatosis. J Physiol. 2019;597:4565-80.
62. Bruinstroop E, Eliveld J, Foppen E, et al. Hepatic denervation and dyslipidemia in obese Zucker (fa/fa) rats. Int J Obes. 2015;39:1655-8.
63. Carnagarin R, Tan K, Adams L, et al. Metabolic dysfunction-associated fatty liver disease (MAFLD) - a condition associated with heightened sympathetic activation. Int J Mol Sci. 2021;22:4241.
64. Raulin A, Martens YA, Bu G. Lipoproteins in the central nervous system: from biology to pathobiology. Annu Rev Biochem. 2022;91:731-59.
65. Zhu Y, Yao L, Gallo-ferraz AL, et al. Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat. Nature. 2024;634:243-50.
66. Hackl MT, Fürnsinn C, Schuh CM, et al. Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis. Nat Commun. 2019;10:2717.
67. Metz M, Beghini M, Wolf P, et al. Leptin increases hepatic triglyceride export via a vagal mechanism in humans. Cell Metab. 2022;34:1719-1731.e5.
68. Hwang J, Lee S, Okada J, et al. Liver-innervating vagal sensory neurons are indispensable for the development of hepatic steatosis and anxiety-like behavior in diet-induced obese mice. Nat Commun. 2025;16:991.
69. Elsing C, Hubner C, Fitscher BA, Kassner A, Stremmel W. Muscarinic acetylcholine receptor stimulation of biliary epithelial cells and its effect on bile secretion in the isolated perfused liver. Hepatology. 1997;25:804-13.
70. Friman S, Radberg G, Svanvik J. Adrenergic influence on bile secretion - an experimental study in the cat. Acta Physiol Scand. 2008;140:287-93.
71. Wang F, Lu Z, Wang X, Zhang Y. Impaired vagus function in rats suppresses bile acid synthesis in the liver by disrupting tight junctions and activating Fxr-Fgf15 signaling in the intestine. Biochem Biophys Res Commun. 2018;495:1490-6.
72. Chen C, Peng S, Chou Y, et al. Human liver afferent and efferent nerves revealed by 3-D/Airyscan super-resolution imaging. Am J Physiol-Endoc M. 2024;326:E107-23.
73. Rossen ND, Touhara KK, Castro J, et al. Population imaging of enterochromaffin cell activity reveals regulation by somatostatin. Proc. Natl. Acad. Sci. U.S.A. 2025;122:e2501525122.
74. Ohtani N, Kamiya T, Kawada N. Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond. Hepatol Commun. 2023;7.
75. Kang JW, Vemuganti V, Kuehn JF, Ulland TK, Rey FE, Bendlin BB. Gut microbial metabolism in Alzheimer’s disease and related dementias. Neurotherapeutics. 2024;21:e00470.
76. Van Munster KN, Bergquist A, Ponsioen CY. Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two? J Hepatol. 2024;80:155-68.
77. Kalaitzakis E. Gastrointestinal dysfunction in liver cirrhosis. World J Gastroenterol. 2014;20:14686.
78. Wang S, Farokhian A, Shen B. Clinical association between inflammatory bowel disease and primary sclerosing cholangitis: what changes after colectomy and liver transplantation? egastro. 2025;3:e100199.
79. Günzel D, Fromm M. Claudins and other tight junction proteins. in: prakash ys, editors. comprehensive physiology. Wiley; 2012. pp. 1819-52.
80. Bonaz B, Sinniger V, Pellissier S. Anti‐inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. The Journal of Physiology. 2016;594:5781-90.
81. Nijhuis LE, Olivier BJ, De Jonge WJ. Neurogenic regulation of dendritic cells in the intestine. Biochem Pharmacol. 2010;80:2002-8.
82. Nakai A, Suzuki K. Adrenergic control of lymphocyte trafficking and adaptive immune responses. Neurochem Int. 2019;130:104320.
83. Henriksen EKK, Jørgensen KK, Kaveh F, et al. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease. J Hepatol. 2017;66:116-22.
84. Liang H, Xu L, Zhou C, Zhang Y, Xu M, Zhang C. Vagal activities are involved in antigen‐specific immune inflammation in the intestine. J Gastroenterol Hepatol. 2011;26:1065-71.
85. Langness S, Kojima M, Coimbra R, Eliceiri BP, Costantini TW. Enteric glia cells are critical to limiting the intestinal inflammatory response after injury. Am J Physiol - Gastrointest Liver Physiol. 2017;312:G274-82.
86. Teratani T, Mikami Y, Nakamoto N, et al. The liver-brain-gut neural arc maintains the Treg cell niche in the gut. Nature. 2020;585:591-6.
87. He X, Hu M, Xu Y, et al. The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis. Nat Med. 2025;31:627-38.
88. Sun J, Debosch BJ. Reciprocal oscillation and host-microbial communication in liver metabolic control. Gut Microbes. 2025;17:2545413.
89. Zhang J, Chen K, Chen F. Exploring the impact of the liver-intestine-brain axis on brain function in non-alcoholic fatty liver disease. J Pharm Anal. 2025;15:101077.
90. Zhang T, Wang W, Li J, et al. Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota. Nat Microbiol. 2025;10:348-61.
91. Li H, Yuan W, Tian Y, et al. Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1. Arch Biochem Biophys. 2022;725:109269.
92. Wan M. Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications. Am J Transl Res. 2025;17:3276-92.
93. Kwiecien S, Sliwowski Z, Pajdo R, Ptak-Belowska A, Brzozowski T. Role of brain-gut axis in mechanism of gastrointestinal defense. J Physiol Pharmacol. 2025;76:487-99.
94. Raybould HE. Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J Physiol Biochem. 2008;64:349-56.
95. Secher A, Jelsing J, Baquero AF, et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Investig. 2014;124:4473-88.
96. Dai F, Yin J, Chen JDZ. Effects and mechanisms of vagal nerve stimulation on body weight in diet-induced obese rats. Obes Surg. 2020;30:948-56.
97. Krieger J, Arnold M, Pettersen KG, Lossel P, Langhans W, Lee SJ. Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia. Diabetes. 2016;65:34-43.
98. Hoffman S, Alvares D, Adeli K. GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein. Molecular Metabolism. 2022;65:101590.
99. Visschers RG, Luyer MD, Schaap FG, Olde Damink SW, Soeters PB. The gut-liver axis. Curr Opin Clin Nutr Metab Care. 2013;16:576-81.
100. Muller PA, Matheis F, Schneeberger M, Kerner Z, Jové V, Mucida D. Microbiota-modulated CART+ enteric neurons autonomously regulate blood glucose. Science. 2020;370:314-21.
101. Macpherson AJ, Pachnis V, Prinz M. Boundaries and integration between microbiota, the nervous system, and immunity. Immunity. 2023;56:1712-26.
102. Pan L, Xie L, Yang W, et al. The role of brain-liver-gut axis in neurological disorders. Burns & Trauma. 2025;13:tkaf011.
103. Chen W, Deng F, Tsai Y. Lactiplantibacillus plantarum as a psychobiotic strategy targeting parkinson’s disease: a review and mechanistic insights. Nutrients. 2025;17:3047.
104. Ren W, Chen J, Wang W, et al. Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function. Neuron. 2024;112:972-990.e8.
105. Cook TM, Gavini CK, Jesse J, et al. Vagal neuron expression of the microbiota-derived metabolite receptor, free fatty acid receptor (FFAR3), is necessary for normal feeding behavior. Mol Metab. 2021;54:101350.
106. Sharma D, Malik A, Locher V, et al. A myeloid Tet2-IL-1β axis modulates intestinal inflammation by restricting catecholaminergic stimulation of enterochromaffin cell differentiation. Immunity. 2025;58:2785-2798.e4.
107. Shen B, Gu T, Shen Z, et al. Escherichia coli promotes endothelial to mesenchymal transformation of liver sinusoidal endothelial cells and exacerbates nonalcoholic fatty liver disease via its flagellin. Cell Mol Gastroenterol Hepatol. 2023;16:857-79.
108. Ahmed O, Caravaca AS, Crespo M, et al. Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation. Bioelectron Med. 2023;9:6.
109. Boicean A, Birlutiu V, Ichim C, Brusnic O, Onișor DM. Fecal microbiota transplantation in liver cirrhosis. Biomedicines. 2023;11:2930.
110. Wu L, Li J, Zou J, Tang D, Chen R. Vagus nerve modulates acute-on-chronic liver failure progression via CXCL9. Chin Med J (Engl). 2024;138:1103-15.
111. Siripen N, Chonprasertsuk S, Aumpan N, Siramolpiwat S. Efficacy of a 12-week supervised home-based exercise program and nutritional supplementation in cirrhotic patients with sarcopenia: A prospective pilot study. Clinical Nutrition ESPEN. 2026;72:102810.
112. Carabotti M, Scirocco A, Maselli M A, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203-9.
113. Gershon MD, Margolis KG. The gut, its microbiome, and the brain: connections and communications. J Clin Investig. 2021;131:e143768.
114. Bonaz B, Sinniger V, Pellissier S. Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease. J Intern Med. 2017;282:46-63.
115. Xie Z, Zhang X, Zhao M, et al. The gut-to-brain axis for toxin-induced defensive responses. Cell. 2022;185:4298-4316.e21.
116. Coulter AA, Rebello CJ, Greenway FL. Centrally acting agents for obesity: past, present, and future. Drugs. 2018;78:1113-32.
117. Ma L, Wang H, Hashimoto K. The vagus nerve: an old but new player in brain-body communication. Brain, Behavior, and Immunity. 2025;124:28-39.
118. Patterson TT, Nicholson S, Wallace D, Hawryluk GW, Grandhi R. Complex feed-forward and feedback mechanisms underlie the relationship between traumatic brain injury and the gut-microbiota-brain axis. Shock. 2019;52:318-25.
119. Yang Y, Eguchi A, Wan X, Mori C, Hashimoto K. Depression-like phenotypes in mice with hepatic ischemia/reperfusion injury: A role of gut-microbiota-liver-brain axis via vagus nerve. J Affect Disord. 2024;345:157-67.
120. Yang X, Qiu K, Jiang Y, Huang Y, Zhang Y, Liao Y. Metabolic crosstalk between liver and brain: from diseases to mechanisms. Int J Mol Sci. 2024;25:7621.
121. Yin J. Transcutaneous vagal nerve stimulation for gastrointestinal disorders. J Transl Gastroenterol. 2025;000:000.
122. Hong GS, Zillekens A, Schneiker B, et al. Non‐invasive transcutaneous auricular vagus nerve stimulation prevents postoperative ileus and endotoxemia in mice. Neurogastroenterology Motil. 2018;31:e13501.
123. Jin H, Guo J, Liu J, et al. Anti-inflammatory effects and mechanisms of vagal nerve stimulation combined with electroacupuncture in a rodent model of TNBS-induced colitis. Am J Physiol - Gastrointest Liver Physiol. 2017;313:G192-202.
124. Sahn B, Pascuma K, Kohn N, Tracey KJ, Markowitz JF. Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial. Bioelectron Med. 2023;9:23.
125. Brinkman DJ, Simon T, Ten Hove AS, et al. Electrical stimulation of the splenic nerve bundle ameliorates dextran sulfate sodium-induced colitis in mice. J Neuroinflammation. 2022;19:155.
126. Zhu Y, Xu F, Lu D, et al. Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia by enhancing vagal efferent activity. Am J Physiol - Gastrointest Liver Physiol. 2021;320:G700-11.
127. Shi X, Hu Y, Zhang B, Li W, Chen JD, Liu F. Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight. 2021;6:e150052.
128. Yuan P, Taché Y. Abdominal surgery induced gastric ileus and activation of M1-like macrophages in the gastric myenteric plexus: prevention by central vagal activation in rats. Am J Physiol - Gastrointest Liver Physiol. 2017;313:G320-9.
129. Jiang Y, Wu L, Zhu X, Bian H, Gao X, Xia M. Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics. Lipids Health Dis. 2024;23:95.
130. Liu A, Huang M, Xi Y, Deng X, Xu K. Orchestration of gut-liver-associated transcription factors in MAFLD: from cross-organ interactions to therapeutic innovation. Biomedicines. 2025;13:1422.
131. John S, Bhowmick K, Park A, Huang H, Yang X, Mishra L. Recent advances in targeting obesity, with a focus on TGF-β signaling and vagus nerve innervation. Bioelectron Med. 2025;11:10.
132. Ueda T, Tategaki A, Hamada K, et al. Effects of Pediococcus acidilactici R037 on serum triglyceride levels in mice and rats after oral administration. J Nutr Sci Vitaminol. 2018;64:41-7.
133. Feng R, Yang W, Feng W, et al. Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling. Gut Microbes. 2024;16:2390164.
134. Gupta H, Suk KT, Kim DJ. Gut microbiota at the intersection of alcohol, brain, and the liver. JCM. 2021;10:541.
135. Pan Y, Yang Y, Wu J, Zhou H, Yang C. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol. 2024;24:283.
136. Kobayashi H, Iida T, Ochiai Y, et al. Neuro-mesenchymal interaction mediated by a β2-adrenergic nerve growth factor feedforward loop promotes colorectal cancer progression. Cancer Discovery. 2025;15:202-26.
137. Wang T, Teng B, Yao DR, Gao W, Oka Y. Organ-specific sympathetic innervation defines visceral functions. Nature. 2024;637:895-902.
138. Shi X, Zhao L, Luo H, et al. Transcutaneous auricular vagal nerve stimulation is effective for the treatment of functional dyspepsia: a multicenter, randomized controlled study. Am J Gastroenterol. 2024;119:521-31.
139. Kovacic K, Hainsworth K, Sood M, et al. Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial. Lancet Gastroenterol Hepatol. 2017;2:727-37.
140. Krasaelap A, Sood MR, Li B, et al. Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double-blind Trial. Clin Gastroenterol Hepatol. 2020;18:1987-1994.e2.
141. Huang Z, Lin Z, Lin C, et al. Transcutaneous electrical acustimulation improves irritable bowel syndrome with constipation by accelerating colon transit and reducing rectal sensation using autonomic mechanisms. Am J Gastroenterol. 2022;117:1491-501.
142. Zhou J, Wang J, Ning B, et al. Sustained ameliorating effects and autonomic mechanisms of transcutaneous electrical acustimulation at ST36 in patients with chronic constipation. Front Neurosci. 2022;16:1038922.
143. Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: a randomized trial. Ann Intern Med. 2016;165:761-9.
144. Liu B, Wu J, Yan S, et al. Electroacupuncture vs prucalopride for severe chronic constipation: a multicenter, randomized, controlled, noninferiority trial. Am J Gastroenterol. 2021;116:1024-35.
145. Iqbal F, Thomas GP, Tan E, et al. Transcutaneous sacral electrical stimulation for chronic functional constipation. Diseases of the Colon & Rectum. 2016;59:132-9.
146. Iqbal F, Collins B, Thomas GP, et al. Bilateral transcutaneous tibial nerve stimulation for chronic constipation. Colorectal Dis. 2016;18:173-8.
147. Gokce AH, Gokce FS. Effects of bilateral transcutaneous tibial nerve stimulation on constipation severity in geriatric patients: a prospective clinical study. Geriatrics Gerontology Int. 2019;20:101-5.
148. Chase J, Robertson VJ, Southwell B, Hutson J, Gibb S. Pilot study using transcutaneous electrical stimulation (interferential current) to treat chronic treatment‐resistant constipation and soiling in children. J Gastroenterol Hepatol. 2005;20:1054-61.
149. Clarke MC, Chase JW, Gibb S, et al. Decreased colonic transit time after transcutaneous interferential electrical stimulation in children with slow transit constipation. J Pediatr Surg. 2009;44:408-12.
150. Clarke MC, Chase JW, Gibb S, Hutson JM, Southwell BR. Improvement of quality of life in children with slow transit constipation after treatment with transcutaneous electrical stimulation. J Pediatr Surg. 2009;44:1268-73.
151. Ismail KA, Chase J, Gibb S, et al. Daily transabdominal electrical stimulation at home increased defecation in children with slow-transit constipation: a pilot study. J Pediatr Surg. 2009;44:2388-92.
152. Yik YI, Ismail KA, Hutson JM, Southwell BR. Home transcutaneous electrical stimulation to treat children with slow-transit constipation. J Pediatr Surg. 2012;47:1285-90.
153. Queralto M, Vitton V, Bouvier M, Abysique A, Portier G. Interferential therapy: a new treatment for slow transit constipation. A pilot study in adults. Colorectal Dis. 2012;15.
154. Clarke MC, Catto-smith AG, King SK, et al. Transabdominal electrical stimulation increases colonic propagating pressure waves in paediatric slow transit constipation. J Pediatr Surg. 2012;47:2279-84.
155. Yang Y, Yim J, Choi W, Lee S. Improving slow-transit constipation with transcutaneous electrical stimulation in women: A randomized, comparative study. Women & Health. 2016;57:494-507.
156. Moore JS, Gibson PR, Burgell RE. Randomised clinical trial: transabdominal interferential electrical stimulation vs sham stimulation in women with functional constipation. Aliment Pharmacol Ther. 2020;51:760-9.
157. Xiao W, Liu Y. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis Sci. 2004;49:312-9.
158. Xiao Y, Xu F, Lin L, Chen JD. Transcutaneous Electrical Acustimulation Improves Constipation by Enhancing Rectal Sensation in Patients With Functional Constipation and Lack of Rectal Sensation. Clin Transl Gastroenterol. 2022;13:e00485.
159. Çoban Ş, Akbal E, Köklü S, et al. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study. Digestion. 2012;86:86-93.
160. Adams D. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain. 2000;123:1495-504.
161. Zhao J, Zhao X, Wang Q, et al. Efficacy and safety of electroacupuncture for metabolic dysfunction-associated fatty liver disease: a study protocol for a multicentre, randomised, sham acupuncture-controlled, patient-blinded clinical trial. BMJ Open. 2024;14:e084768.
162. Fu L, Huang L, Gao Y, et al. Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial. BMJ Open. 2024;14:e081293.
